디지털 바이오제조 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Digital Biomanufacturing Market - Scope of Report

TMR's report on the global digital biomanufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global digital biomanufacturing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital biomanufacturing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital biomanufacturing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital biomanufacturing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital biomanufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital biomanufacturing market.

The report delves into the competitive landscape of the global digital biomanufacturing market. Key players operating in the global digital biomanufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital biomanufacturing market profiled in this report.

Key Questions Answered in global digital biomanufacturing Market Report:

• What is the sales/revenue generated by digital biomanufacturing across all regions during the forecast period?
• What are the opportunities in the global digital biomanufacturing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Digital Biomanufacturing Market - Research Objectives and Research Approach

The comprehensive report on the global digital biomanufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global digital biomanufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital biomanufacturing market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Digital Biomanufacturing Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Digital Biomanufacturing Market Analysis and Forecasts, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. Technological Advancements in Digital Biomanufacturing
• 5.3. List of Players offering Manufacturing Execution System (MES) Solutions
• 5.4. List of Players offering Process Analytical Technology (PAT) Solutions
• 5.5. Regulatory Scenario across Key Regions / Countries
• 5.6. PORTER's Five Forces Analysis
• 5.7. PESTEL Analysis
• 5.8. Value Chain Analysis
• 5.9. Key Purchase Metrics for End-users
• 5.10. Go-to-Market Strategy for New Market Entrants
• 5.11. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
• 5.12. Benchmarking of Key Technologies Offered by the Leading Competitors

6. Global Digital Biomanufacturing Market Analysis and Forecasts, By Technology

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Technology, 2020-2035
  • 6.3.1. Manufacturing Execution System (MES)
  • 6.3.2. Process Analytical Biologic Type(PAT)
  • 6.3.3. Data Analytics Software
  • 6.3.4. Digital Twins
• 6.4. Market Attractiveness By Technology

7. Global Digital Biomanufacturing Market Analysis and Forecasts, By Deployment Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Deployment Type, 2020-2035
  • 7.3.1. Cloud-based
  • 7.3.2. On-premises
• 7.4. Market Attractiveness By Deployment Type

8. Global Digital Biomanufacturing Market Analysis and Forecasts, By Biologic Type

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Biologic Type, 2020-2035
  • 8.3.1. Vaccines
  • 8.3.2. Antibodies
  • 8.3.3. Cell and Gene Therapies
  • 8.3.4. Others
• 8.4. Market Attractiveness By Biologic Type

9. Global Digital Biomanufacturing Market Analysis and Forecasts, By Application

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Application, 2020-2035
  • 9.3.1. Biomanufacturing Process Automation
  • 9.3.2. Remote Equipment Monitoring
  • 9.3.3. Digital Bioreactor Scaling
  • 9.3.4. Others
• 9.4. Market Attractiveness By Application

10. Global Digital Biomanufacturing Market Analysis and Forecasts, By End-user

• 10.1. Introduction & Definition
• 10.2. Key Findings / Developments
• 10.3. Market Value Forecast By End-user, 2020-2035
  • 10.3.1. Biopharmaceutical Companies
  • 10.3.2. Contract Manufacturing Organizations
  • 10.3.3. Others
• 10.4. Market Attractiveness By End-user

11. Global Digital Biomanufacturing Market Analysis and Forecasts, By Region

• 11.1. Key Findings
• 11.2. Market Value Forecast By Region
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness By Region

12. North America Digital Biomanufacturing Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Technology, 2020-2035
  • 12.2.1. Manufacturing Execution System (MES)
  • 12.2.2. Process Analytical Biologic Type(PAT)
  • 12.2.3. Data Analytics Software
  • 12.2.4. Digital Twins
• 12.3. Market Value Forecast By Deployment Type, 2020-2035
  • 12.3.1. Cloud-based
  • 12.3.2. On-premises
• 12.4. Market Value Forecast By Biologic Type, 2020-2035
  • 12.4.1. Vaccines
  • 12.4.2. Antibodies
  • 12.4.3. Cell and Gene Therapies
  • 12.4.4. Others
• 12.5. Market Value Forecast By Application, 2020-2035
  • 12.5.1. Biomanufacturing Process Automation
  • 12.5.2. Remote Equipment Monitoring
  • 12.5.3. Digital Bioreactor Scaling
  • 12.5.4. Others
• 12.6. Market Value Forecast By End-user, 2020-2035
  • 12.6.1. Biopharmaceutical Companies
  • 12.6.2. Contract Manufacturing Organizations
  • 12.6.3. Others
• 12.7. Market Value Forecast By Country, 2020-2035
  • 12.7.1. U.S.
  • 12.7.2. Canada
• 12.8. Market Attractiveness Analysis
  • 12.8.1. By Technology
  • 12.8.2. By Deployment Type
  • 12.8.3. By Biologic Type
  • 12.8.4. By Application
  • 12.8.5. By End-user
  • 12.8.6. By Country

13. Europe Digital Biomanufacturing Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Technology, 2020-2035
  • 13.2.1. Manufacturing Execution System (MES)
  • 13.2.2. Process Analytical Biologic Type(PAT)
  • 13.2.3. Data Analytics Software
  • 13.2.4. Digital Twins
• 13.3. Market Value Forecast By Deployment Type, 2020-2035
  • 13.3.1. Cloud-based
  • 13.3.2. On-premises
• 13.4. Market Value Forecast By Biologic Type, 2020-2035
  • 13.4.1. Vaccines
  • 13.4.2. Antibodies
  • 13.4.3. Cell and Gene Therapies
  • 13.4.4. Others
• 13.5. Market Value Forecast By Application, 2020-2035
  • 13.5.1. Biomanufacturing Process Automation
  • 13.5.2. Remote Equipment Monitoring
  • 13.5.3. Digital Bioreactor Scaling
  • 13.5.4. Others
• 13.6. Market Value Forecast By End-user, 2020-2035
  • 13.6.1. Biopharmaceutical Companies
  • 13.6.2. Contract Manufacturing Organizations
  • 13.6.3. Others
• 13.7. Market Value Forecast By Country / Sub-region, 2020-2035
  • 13.7.1. Germany
  • 13.7.2. U.K.
  • 13.7.3. France
  • 13.7.4. Spain
  • 13.7.5. Italy
  • 13.7.6. Rest of Europe
• 13.8. Market Attractiveness Analysis
  • 13.8.1. By Technology
  • 13.8.2. By Deployment Type
  • 13.8.3. By Biologic Type
  • 13.8.4. By Application
  • 13.8.5. By End-user
  • 13.8.6. By Country / Sub-region

14. Asia Pacific Digital Biomanufacturing Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Technology, 2020-2035
  • 14.2.1. Manufacturing Execution System (MES)
  • 14.2.2. Process Analytical Biologic Type(PAT)
  • 14.2.3. Data Analytics Software
  • 14.2.4. Digital Twins
• 14.3. Market Value Forecast By Deployment Type, 2020-2035
  • 14.3.1. Cloud-based
  • 14.3.2. On-premises
• 14.4. Market Value Forecast By Biologic Type, 2020-2035
  • 14.4.1. Vaccines
  • 14.4.2. Antibodies
  • 14.4.3. Cell and Gene Therapies
  • 14.4.4. Others
• 14.5. Market Value Forecast By Application, 2020-2035
  • 14.5.1. Biomanufacturing Process Automation
  • 14.5.2. Remote Equipment Monitoring
  • 14.5.3. Digital Bioreactor Scaling
  • 14.5.4. Others
• 14.6. Market Value Forecast By End-user, 2020-2035
  • 14.6.1. Biopharmaceutical Companies
  • 14.6.2. Contract Manufacturing Organizations
  • 14.6.3. Others
• 14.7. Market Value Forecast By Country / Sub-region, 2020-2035
  • 14.7.1. China
  • 14.7.2. Japan
  • 14.7.3. India
  • 14.7.4. Australia & New Zealand
  • 14.7.5. Rest of Asia Pacific
• 14.8. Market Attractiveness Analysis
  • 14.8.1. By Technology
  • 14.8.2. By Deployment Type
  • 14.8.3. By Biologic Type
  • 14.8.4. By Application
  • 14.8.5. By End-user
  • 14.8.6. By Country / Sub-region

15. Latin America Digital Biomanufacturing Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Technology, 2020-2035
  • 15.2.1. Manufacturing Execution System (MES)
  • 15.2.2. Process Analytical Biologic Type(PAT)
  • 15.2.3. Data Analytics Software
  • 15.2.4. Digital Twins
• 15.3. Market Value Forecast By Deployment Type, 2020-2035
  • 15.3.1. Cloud-based
  • 15.3.2. On-premises
• 15.4. Market Value Forecast By Biologic Type, 2020-2035
  • 15.4.1. Vaccines
  • 15.4.2. Antibodies
  • 15.4.3. Cell and Gene Therapies
  • 15.4.4. Others
• 15.5. Market Value Forecast By Application, 2020-2035
  • 15.5.1. Biomanufacturing Process Automation
  • 15.5.2. Remote Equipment Monitoring
  • 15.5.3. Digital Bioreactor Scaling
  • 15.5.4. Others
• 15.6. Market Value Forecast By End-user, 2020-2035
  • 15.6.1. Biopharmaceutical Companies
  • 15.6.2. Contract Manufacturing Organizations
  • 15.6.3. Others
• 15.7. Market Value Forecast By Country / Sub-region, 2020-2035
  • 15.7.1. Brazil
  • 15.7.2. Mexico
  • 15.7.3. Rest of Latin America
• 15.8. Market Attractiveness Analysis
  • 15.8.1. By Technology
  • 15.8.2. By Deployment Type
  • 15.8.3. By Biologic Type
  • 15.8.4. By Application
  • 15.8.5. By End-user
  • 15.8.6. By Country / Sub-region

16. Middle East & Africa Digital Biomanufacturing Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast By Technology, 2020-2035
  • 16.2.1. Manufacturing Execution System (MES)
  • 16.2.2. Process Analytical Biologic Type(PAT)
  • 16.2.3. Data Analytics Software
  • 16.2.4. Digital Twins
• 16.3. Market Value Forecast By Deployment Type, 2020-2035
  • 16.3.1. Cloud-based
  • 16.3.2. On-premises
• 16.4. Market Value Forecast By Biologic Type, 2020-2035
  • 16.4.1. Vaccines
  • 16.4.2. Antibodies
  • 16.4.3. Cell and Gene Therapies
  • 16.4.4. Others
• 16.5. Market Value Forecast By Application, 2020-2035
  • 16.5.1. Biomanufacturing Process Automation
  • 16.5.2. Remote Equipment Monitoring
  • 16.5.3. Digital Bioreactor Scaling
  • 16.5.4. Others
• 16.6. Market Value Forecast By End-user, 2020-2035
  • 16.6.1. Biopharmaceutical Companies
  • 16.6.2. Contract Manufacturing Organizations
  • 16.6.3. Others
• 16.7. Market Value Forecast By Country / Sub-region, 2020-2035
  • 16.7.1. GCC Countries
  • 16.7.2. South Africa
  • 16.7.3. Rest of Middle East & Africa
• 16.8. Market Attractiveness Analysis
  • 16.8.1. By Technology
  • 16.8.2. By Deployment Type
  • 16.8.3. By Biologic Type
  • 16.8.4. By Application
  • 16.8.5. By End-user
  • 16.8.6. By Country / Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 17.2. Market Share Analysis By Company (2024)
• 17.3. Company Profiles
  • 17.3.1. Cytiva (Danaher Corporation)
    • 17.3.1.1. Company Overview
    • 17.3.1.2. Financial Overview
    • 17.3.1.3. Product Portfolio
    • 17.3.1.4. Business Strategies
    • 17.3.1.5. Recent Developments
  • 17.3.2. Eppendorf SE
    • 17.3.2.1. Company Overview
    • 17.3.2.2. Financial Overview
    • 17.3.2.3. Product Portfolio
    • 17.3.2.4. Business Strategies
    • 17.3.2.5. Recent Developments
  • 17.3.3. Sartorius AG
    • 17.3.3.1. Company Overview
    • 17.3.3.2. Financial Overview
    • 17.3.3.3. Product Portfolio
    • 17.3.3.4. Business Strategies
    • 17.3.3.5. Recent Developments
  • 17.3.4. Merck KGaA
    • 17.3.4.1. Company Overview
    • 17.3.4.2. Financial Overview
    • 17.3.4.3. Product Portfolio
    • 17.3.4.4. Business Strategies
    • 17.3.4.5. Recent Developments
  • 17.3.5. Aspen Technology Inc
    • 17.3.5.1. Company Overview
    • 17.3.5.2. Financial Overview
    • 17.3.5.3. Product Portfolio
    • 17.3.5.4. Business Strategies
    • 17.3.5.5. Recent Developments
  • 17.3.6. Korber AG
    • 17.3.6.1. Company Overview
    • 17.3.6.2. Financial Overview
    • 17.3.6.3. Product Portfolio
    • 17.3.6.4. Business Strategies
    • 17.3.6.5. Recent Developments
  • 17.3.7. AmpleLogic
    • 17.3.7.1. Company Overview
    • 17.3.7.2. Financial Overview
    • 17.3.7.3. Product Portfolio
    • 17.3.7.4. Business Strategies
    • 17.3.7.5. Recent Developments
  • 17.3.8. Siemens
    • 17.3.8.1. Company Overview
    • 17.3.8.2. Financial Overview
    • 17.3.8.3. Product Portfolio
    • 17.3.8.4. Business Strategies
    • 17.3.8.5. Recent Developments
  • 17.3.9. Thermo Fisher Scientific Inc.
    • 17.3.9.1. Company Overview
    • 17.3.9.2. Financial Overview
    • 17.3.9.3. Product Portfolio
    • 17.3.9.4. Business Strategies
    • 17.3.9.5. Recent Developments
  • 17.3.10. ABB
    • 17.3.10.1. Company Overview
    • 17.3.10.2. Financial Overview
    • 17.3.10.3. Product Portfolio
    • 17.3.10.4. Business Strategies
    • 17.3.10.5. Recent Developments
  • 17.3.11. Bruker
    • 17.3.11.1. Company Overview
    • 17.3.11.2. Financial Overview
    • 17.3.11.3. Product Portfolio
    • 17.3.11.4. Business Strategies
    • 17.3.11.5. Recent Developments
  • 17.3.12. Hamilton Company
    • 17.3.12.1. Company Overview
    • 17.3.12.2. Financial Overview
    • 17.3.12.3. Product Portfolio
    • 17.3.12.4. Business Strategies
    • 17.3.12.5. Recent Developments
  • 17.3.13. Dassault Systemes
    • 17.3.13.1. Company Overview
    • 17.3.13.2. Financial Overview
    • 17.3.13.3. Product Portfolio
    • 17.3.13.4. Business Strategies
    • 17.3.13.5. Recent Developments
  • 17.3.14. Kymanox Corporation
    • 17.3.14.1. Company Overview
    • 17.3.14.2. Financial Overview
    • 17.3.14.3. Product Portfolio
    • 17.3.14.4. Business Strategies
    • 17.3.14.5. Recent Developments
  • 17.3.15. Invert, Inc.
    • 17.3.15.1. Company Overview
    • 17.3.15.2. Financial Overview
    • 17.3.15.3. Product Portfolio
    • 17.3.15.4. Business Strategies
    • 17.3.15.5. Recent Developments
  • 17.3.16. Genedata AG
    • 17.3.16.1. Company Overview
    • 17.3.16.2. Financial Overview
    • 17.3.16.3. Product Portfolio
    • 17.3.16.4. Business Strategies
    • 17.3.16.5. Recent Developments